With the removal of FDA warning labels, hormone therapy to treat symptoms of menopause has grown in popularity. Now some patients are reporting delays in filling prescriptions for estrogen patches.

An increasing number of women who use estrogen patches to help deal with perimenopause and menopause symptoms have been scrambling to access their transdermal drug amid a nationwide shortage of the ...

March 30, 2011 (Toronto, Ontario) — Caregivers using a transdermal patch to administer cholinesterase inhibitor (ChEI)–based therapy in individuals with Alzheimer's disease (AD) report greater overall ...

December 9, 2011 — Voting in favor of the norelgestromin/ethinyl estradiol transdermal contraceptive patch (Ortho Evra, Jannsen), a US Food and Drug Administration (FDA) advisory panel today ...

An informational 2026 consumer report examining Purisaki Berberine Patches' transdermal delivery claims, ingredient research ...